Penn Medicine Abramson Cancer Center


 

Managing mNSCLC Patients: DFS Data on Adjuvant Osimertinib After Resection, Nivo/Ipi & Nivo/Ipi + Chemo for Patients Without a Molecular Target

38 views
March 22, 2021
0 Comments
Login to view comments. Click here to Login
2020 Updates in Oncology